ZyVersa Therapeutics, Inc. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: ZyVersa Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
ZyVersa Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $19.4M, a 40.9% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$19.4M	-$13.4M	-40.9%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$19.5M	-$12.5M	-39.1%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$21.7M	-$93.3M	-81.2%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$22.1M	-$96.4M	-81.3%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$32.9M	-$46.5M	-58.6%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$32M	-$47.2M	-59.6%	Jun 30, 2023	10-Q	2023-08-21
Q1 2023	$115M	+$35.3M	+44.3%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$119M	+$41.4M	+53.6%	Dec 31, 2022	10-K	2024-03-25
Q3 2022	$79.4M			Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$79.2M			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$79.7M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$77.1M			Dec 31, 2021	10-Q	2022-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.